Somewhat Positive Press Coverage Somewhat Unlikely to Affect Univar (UNVR) Share Price
Media stories about Univar (NYSE:UNVR) have trended somewhat positive on Tuesday, Accern Sentiment reports. The research firm identifies positive and negative press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Univar earned a news impact score of 0.15 on Accern’s scale. Accern also gave news coverage about the basic materials company an impact score of 46.3640766588291 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
These are some of the news articles that may have impacted Accern Sentiment’s analysis:
- Global Organometallics Market Size 2018 – Univar USA, Coastal Chemical, Bide Pharmatech and Pfaltz and Bauer (thetechnicalprogress.com)
- Univar Inc. (UNVR) Analysts See $0.38 EPS as of May, 4 (styleonfleek365.com)
- Global Third-Party Chemical Distribution Market 2018 – Univar, Brenntag, HELM, Nexeo Solutions (themobileherald.com)
- Financial Review: Univar (UNVR) vs. The Competition (americanbankingnews.com)
- Hawkins (HWKN) vs. Univar (UNVR) Head-To-Head Comparison (americanbankingnews.com)
UNVR stock opened at $28.83 on Tuesday. The stock has a market capitalization of $3,987.99, a price-to-earnings ratio of 20.74, a price-to-earnings-growth ratio of 1.93 and a beta of 1.21. The company has a debt-to-equity ratio of 2.59, a current ratio of 1.77 and a quick ratio of 1.18. Univar has a 12 month low of $25.79 and a 12 month high of $32.53.
Several research analysts recently weighed in on the stock. TheStreet upgraded shares of Univar from a “c+” rating to a “b-” rating in a research report on Monday, April 2nd. ValuEngine downgraded shares of Univar from a “hold” rating to a “sell” rating in a research report on Monday, April 2nd. Deutsche Bank set a $34.00 price target on shares of Univar and gave the stock a “hold” rating in a research report on Wednesday, March 7th. Zacks Investment Research downgraded shares of Univar from a “buy” rating to a “hold” rating in a research report on Tuesday, February 27th. Finally, Vertical Research upgraded shares of Univar from a “sell” rating to a “hold” rating in a research report on Tuesday, February 20th. Three analysts have rated the stock with a sell rating, three have assigned a hold rating and four have given a buy rating to the company’s stock. Univar currently has a consensus rating of “Hold” and a consensus price target of $32.67.
In other Univar news, major shareholder Dahlia Investments Pte. Ltd. sold 75,587 shares of the stock in a transaction dated Wednesday, January 17th. The shares were sold at an average price of $31.14, for a total value of $2,353,779.18. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In the last quarter, insiders sold 93,587 shares of company stock valued at $2,914,052. 0.55% of the stock is owned by insiders.
TRADEMARK VIOLATION WARNING: This news story was reported by Daily Political and is the sole property of of Daily Political. If you are accessing this news story on another website, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The original version of this news story can be viewed at https://www.dailypolitical.com/2018/04/16/somewhat-positive-press-coverage-somewhat-unlikely-to-affect-univar-unvr-share-price.html.
Univar Company Profile
Univar Inc is a distributor of commodity and specialty chemicals. The Company operates through four segments: Univar USA (USA); Univar Canada (Canada); Univar Europe and the Middle East and Africa (EMEA), and Rest of World. The Company’s USA segment supplies a range of commodity and specialty chemicals, as well as services to a range of end markets, including manufacturing and industrial production sectors in the United States.
Receive News & Ratings for Univar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Univar and related companies with MarketBeat.com's FREE daily email newsletter.